Patients are expected to enroll in the post-marketing study in the coming weeks, following approval from the Institutional Review Board of West Cancer Center & Research Institute in Germantown, TN CAESAREA, Israel, Aug. 20, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM)...
Hence then, the article about west cancer center receives irb approval to commence icecure s choice study for breast cancer cryoablation was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation )
Also on site :
- Solidion Technology (NASDAQ: STI) Remains Firm on Flux Power (NASDAQ: FLUX) Below Market Offer in Response to Flux Board Rejection
- Solidion Technology (NASDAQ : STI) maintient sa position sur Flux Power (NASDAQ : FLUX) offre inférieure au cours du marché en réponse au rejet par le conseil d'administration de Flux
- Karl Deisseroth, Peter Hegemann, Georg Nagel win Nobel 2026 in medicine